References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404–11.
Yang L, Sun X, Zou Y, Meng X. Small cell type neuroendocrine carcinoma colliding with squamous cell carcinoma at esophagus. Int J Clin Exp Pathol. 2014;7(4):1792–5.
Dias AR, Sallum RA, Zalc N, Ctenas BB, Ribeiro U, Cecconello I. Squamous cell carcinoma and neuroendocrine carcinoma colliding in the esophagus. Clinics (Sao Paulo). 2010;65(1):114–7.
Mosnier JF, Balique JG. Pleomorphic giant cell carcinoma of the esophagus with coexpression of cytokeratin and vimentin and neuroendocrine differentiation. Arch Pathol Lab Med. 2000;124:135–8.
Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112–20.
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813–29.
Lee CG, Lim YJ, Park SJ, Jang BI, Choi SR, Kim JK, et al. The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea. BMC Cancer. 2014;14:569.
Lipka S, Hurtado-Cordovi J, Avezbakiyev B, Freedman L, Clark T, Rizvon K, et al. Synchronous small cell neuroendocrine carcinoma and adenocarcinoma of the colon: a link for common stem cell origin? ACG Case Rep J. 2014;1(2):96–9.
Allen JW, Richardson JD, Edwards MJ. Squamous cell carcinoma of the esophagus: a review and update. Surg Oncol. 1997;6(4):193–200.
Wang KK. Detection and staging of esophageal cancers. Curr Opin Gastroenterol. 2004;20:381–5.
Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive series. BMJ. 1997;314:467–70.
Lloyd S, Chang BW. Current strategies in chemoradiation for esophageal cancer. J Gastrointest Oncol. 2014;5(3):156–65.
Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J, et al. Survival benefits from neoadjuvent chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8(3):226–34.
Ellis Jr FH, Gibb SP, Watkins Jr E. Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg. 1983;198:531–40.
Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, et al. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37:467–83.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Khonglah, Y., Jitani, A.K., Gogoi, B.B. et al. Concurrent Lesions in Oesophagus: an Approach to Diagnosis with a Case Report. J Gastrointest Canc 48, 201–204 (2017). https://doi.org/10.1007/s12029-016-9822-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-016-9822-8